Victoria Jenkins, PhD

Bavarian Nordic
Zug, Zug, Switzerland

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 2888 - Safety and Immunogenicity of an Adjuvanted Chikungunya Virus (CHIKV) Virus-like Particle (VLP) Based Vaccine in Two Pivotal Phase 3 Trials, ≥12 Years of Age

  Saturday, October 14, 2023
  1:45 PM – 1:55 PM US ET